Page 21 - ஏருசலேம் ஹீப்ரு பல்கலைக்கழகம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The study has not yet been peer reviewed and neither Pfizer nor the Israeli Health Ministry have made public comment on the findings, but the early signs are good. A different study by Israel’s Sheba Medical Centre also found that among 7,214 hospital staff who were given their first dose, there was a reduction of 85 per cent in symptomatic Covid-19 within 15 to 28 days, and an overall reduction of infections, including asymptomatic cases detected by testing, of 75%. Michal Linial, a professor of molecular biology and bioinformatics at Jerusalem’s Hebrew University, spoke positively of the findings. Whether it is 75 or 90 percent reduction doesn’t matter - it is a big drop in transmission, Linial said.

Israel generalBiontech covidMichal linialPfizer incIsrael sheba medical centreIsraeli health ministryJerusalem hebrew universitySheba medical centreHebrew universityCovid 19Covid 19 vaccineஇஸ்ரேல் ஜநரல்ஃபைசர் இன்க்இஸ்ரேல் ஷெபா மருத்துவ மையம்இஸ்ரேலி ஆரோக்கியம் அமைச்சகம்ஏருசலேம் ஹீப்ரு பல்கலைக்கழகம்